These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 36378589)

  • 21. FIB-4, APRI, and AST/ALT ratio compared to FibroScan for the assessment of hepatic fibrosis in patients with non-alcoholic fatty liver disease in Bandar Abbas, Iran.
    Amernia B; Moosavy SH; Banookh F; Zoghi G
    BMC Gastroenterol; 2021 Dec; 21(1):453. PubMed ID: 34861841
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical usefulness of biochemical markers of liver fibrosis in patients with nonalcoholic fatty liver disease.
    Sakugawa H; Nakayoshi T; Kobashigawa K; Yamashiro T; Maeshiro T; Miyagi S; Shiroma J; Toyama A; Nakayoshi T; Kinjo F; Saito A
    World J Gastroenterol; 2005 Jan; 11(2):255-9. PubMed ID: 15633226
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vitamin D levels do not predict the stage of hepatic fibrosis in patients with non-alcoholic fatty liver disease: A PRISMA compliant systematic review and meta-analysis of pooled data.
    Saberi B; Dadabhai AS; Nanavati J; Wang L; Shinohara RT; Mullin GE
    World J Hepatol; 2018 Jan; 10(1):142-154. PubMed ID: 29399288
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum β-trophin level as a new marker for noninvasive assessment of nonalcoholic fatty liver disease and liver fibrosis.
    Cengiz M; Ozenirler S; Kocabiyik M
    Eur J Gastroenterol Hepatol; 2016 Jan; 28(1):57-63. PubMed ID: 26513612
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PERFORMACE OF TRIGLYCERIDE-GLUCOSE INDEX ON DIAGNOSIS AND STAGING OF NAFLD IN OBESE PATIENTS.
    Smiderle CA; Coral GP; DE Carli LA; Mattos AA; Mattos AZ; Tovo CV
    Arq Gastroenterol; 2021; 58(2):139-144. PubMed ID: 34231659
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Derivation and validation of the nonalcoholic fatty liver disease cirrhosis score (NCS) to distinguish bridging fibrosis from cirrhosis.
    Labenz C; Toenges G; Zheng MH; Ding D; Myers RP; Galle PR; Armandi A; Ampuero J; Gómez MR; Bugianesi E; Anstee QM; Schattenberg JM
    Eur J Intern Med; 2022 Apr; 98():53-60. PubMed ID: 35058147
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of non-invasive parameters of non-alcoholic steatohepatitis and liver fibrosis in daily practice--an exploratory case-control study.
    Dvorak K; Stritesky J; Petrtyl J; Vitek L; Sroubkova R; Lenicek M; Smid V; Haluzik M; Bruha R
    PLoS One; 2014; 9(10):e111551. PubMed ID: 25350286
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Accuracy of Transient Elastography Data Combined With APRI in Detection and Staging of Liver Disease in Pediatric Patients With Cystic Fibrosis.
    Lewindon PJ; Puertolas-Lopez MV; Ramm LE; Noble C; Pereira TN; Wixey JA; Hartel GF; Calvopina DA; Leung DH; Ramm GA
    Clin Gastroenterol Hepatol; 2019 Nov; 17(12):2561-2569.e5. PubMed ID: 30880274
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Magnetic resonance elastography in staging liver fibrosis in non-alcoholic fatty liver disease: a pooled analysis of the diagnostic accuracy.
    Liang Y; Li D
    BMC Gastroenterol; 2020 Apr; 20(1):89. PubMed ID: 32252641
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correlation of Serum Transaminase Levels with Liver Fibrosis Assessed by Transient Elastography in Vietnamese Patients with Nonalcoholic Fatty Liver Disease.
    Thong VD; Quynh BTH
    Int J Gen Med; 2021; 14():1349-1355. PubMed ID: 33889015
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vibration-controlled Transient Elastography in NAFLD: Review Study.
    Ozercan AM; Ozkan H
    Euroasian J Hepatogastroenterol; 2022 Jul; 12(Suppl 1):S41-S45. PubMed ID: 36466098
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Validation of Serum Test for Advanced Liver Fibrosis in Patients With Nonalcoholic Steatohepatitis.
    Loomba R; Jain A; Diehl AM; Guy CD; Portenier D; Sudan R; Singh S; Faulkner C; Richards L; Hester KD; Okada L; Li XJ; Mimms L; Abdelmalek MF
    Clin Gastroenterol Hepatol; 2019 Aug; 17(9):1867-1876.e3. PubMed ID: 30448594
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased serum soluble lectin-like oxidized low-density lipoprotein receptor-1 levels in patients with biopsy-proven nonalcoholic fatty liver disease.
    Ozturk O; Colak Y; Senates E; Yilmaz Y; Ulasoglu C; Doganay L; Ozkanli S; Oltulu YM; Coskunpinar E; Tuncer I
    World J Gastroenterol; 2015 Jul; 21(26):8096-102. PubMed ID: 26185381
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum cytokeratin-18 fragment levels as noninvasive marker of nonalcoholic steatohepatitis in the chilean population.
    Arab JP; Hernández-Rocha C; Morales C; Vargas JI; Solís N; Pizarro M; Robles C; Sandoval D; Ponthus S; Benítez C; Barrera F; Soza A; Riquelme A; Arrese M
    Gastroenterol Hepatol; 2017; 40(6):388-394. PubMed ID: 28359548
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Advanced fibrosis in nonalcoholic fatty liver disease: noninvasive assessment with MR elastography.
    Kim D; Kim WR; Talwalkar JA; Kim HJ; Ehman RL
    Radiology; 2013 Aug; 268(2):411-9. PubMed ID: 23564711
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Measurements of serum procollagen-III peptide and M30 do not improve the diagnostic accuracy of transient elastography for the detection of hepatic fibrosis in patients with nonalcoholic fatty liver disease.
    Ergelen R; Akyuz U; Aydin Y; Eren F; Yilmaz Y
    Eur J Gastroenterol Hepatol; 2015 Jun; 27(6):667-71. PubMed ID: 25923941
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Diagnostic value of liver stiffness measurement for the evaluation of liver fibrosis in nonalcoholic fatty liver].
    Ning J; Yao MJ; Liu SH; Zhou GD; Zhang Y; Li MY; Wang LJ; Wang L; Zhao JM; Lu FM
    Zhonghua Gan Zang Bing Za Zhi; 2020 Jul; 28(7):567-572. PubMed ID: 32791791
    [No Abstract]   [Full Text] [Related]  

  • 38. Real time shear wave elastography in chronic liver diseases: accuracy for predicting liver fibrosis, in comparison with serum markers.
    Jeong JY; Kim TY; Sohn JH; Kim Y; Jeong WK; Oh YH; Yoo KS
    World J Gastroenterol; 2014 Oct; 20(38):13920-9. PubMed ID: 25320528
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Role of Multiparametric US of the Liver for the Evaluation of Nonalcoholic Steatohepatitis.
    Sugimoto K; Moriyasu F; Oshiro H; Takeuchi H; Abe M; Yoshimasu Y; Kasai Y; Sakamaki K; Hara T; Itoi T
    Radiology; 2020 Sep; 296(3):532-540. PubMed ID: 32573385
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The combination of liver stiffness measurement and NAFLD fibrosis score improves the noninvasive diagnostic accuracy for severe liver fibrosis in patients with nonalcoholic fatty liver disease.
    Petta S; Vanni E; Bugianesi E; Di Marco V; Cammà C; Cabibi D; Mezzabotta L; Craxì A
    Liver Int; 2015 May; 35(5):1566-73. PubMed ID: 24798049
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.